ATE160573T1 - 1,3.5 (10) - estratriene derivate mit oraler wirkung - Google Patents
1,3.5 (10) - estratriene derivate mit oraler wirkungInfo
- Publication number
- ATE160573T1 ATE160573T1 AT94928126T AT94928126T ATE160573T1 AT E160573 T1 ATE160573 T1 AT E160573T1 AT 94928126 T AT94928126 T AT 94928126T AT 94928126 T AT94928126 T AT 94928126T AT E160573 T1 ATE160573 T1 AT E160573T1
- Authority
- AT
- Austria
- Prior art keywords
- estratrienic
- derivatives
- beta
- oral action
- oral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/122,853 US5554603A (en) | 1993-09-17 | 1993-09-17 | Orally active derivatives of 1,3,5(10)-estratriene |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE160573T1 true ATE160573T1 (de) | 1997-12-15 |
Family
ID=22405185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94928126T ATE160573T1 (de) | 1993-09-17 | 1994-09-15 | 1,3.5 (10) - estratriene derivate mit oraler wirkung |
Country Status (11)
Country | Link |
---|---|
US (1) | US5554603A (de) |
EP (1) | EP0719276B1 (de) |
JP (1) | JP3993228B2 (de) |
AT (1) | ATE160573T1 (de) |
AU (1) | AU700576B2 (de) |
CA (1) | CA2171740C (de) |
DE (1) | DE69407057T2 (de) |
DK (1) | DK0719276T3 (de) |
ES (1) | ES2110258T3 (de) |
GR (1) | GR3025872T3 (de) |
WO (1) | WO1995007925A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6548491B2 (en) | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
AU2004237574A1 (en) * | 2003-03-13 | 2004-11-18 | Nitromed, Inc. | Nitrosated and nitrosylated compounds, compositions and methods of use |
JP2008500368A (ja) * | 2004-05-27 | 2008-01-10 | ミジェニックス コーポレイション | 細胞保護のための2置換17−イミノエストロゲン化合物 |
EP2265629B1 (de) * | 2008-03-05 | 2015-06-24 | Evestra, Inc. | Bismethylen-17-carbolactone und damit in zusammenhang stehende anwendungen |
US20090269403A1 (en) * | 2008-04-24 | 2009-10-29 | Shaked Ze Ev | Oral contraceptive dosage forms and methods of making such dosage forms |
EP2367808A4 (de) * | 2008-11-25 | 2012-05-09 | Evestra Inc | PROGESTATIVE 3-(6,6-ETHYLEN-17b-HYDROXY-3-OXO-17a-PREGNA-4-EN-17a-YL) PROPIONSÄURE-g-LACTONE |
AU2011238710B2 (en) * | 2010-03-28 | 2015-08-20 | Evestra, Inc. | Intravaginal drug delivery device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1074493A (en) * | 1963-06-12 | 1967-07-05 | Roussel Uclaf | Novel estrane derivatives and processes for preparing them |
FR5241M (de) * | 1966-02-24 | 1967-07-17 | ||
NL135316C (de) * | 1966-11-18 | |||
GB1332784A (en) * | 1969-11-21 | 1973-10-03 | Glaxo Lab Ltd | Nitrates of steroid 11 beta-ols |
US3980681A (en) * | 1969-11-21 | 1976-09-14 | Peter Job Sykes | Process for the preparation of 11-β-nitro-oxysteroids |
US4705783A (en) * | 1985-06-25 | 1987-11-10 | Sri International | 9α, 11β-substituted and 11β-substituted estranes |
-
1993
- 1993-09-17 US US08/122,853 patent/US5554603A/en not_active Expired - Lifetime
-
1994
- 1994-09-15 DK DK94928126T patent/DK0719276T3/da active
- 1994-09-15 AU AU77284/94A patent/AU700576B2/en not_active Expired
- 1994-09-15 DE DE69407057T patent/DE69407057T2/de not_active Expired - Lifetime
- 1994-09-15 CA CA002171740A patent/CA2171740C/en not_active Expired - Lifetime
- 1994-09-15 ES ES94928126T patent/ES2110258T3/es not_active Expired - Lifetime
- 1994-09-15 WO PCT/US1994/010393 patent/WO1995007925A1/en active IP Right Grant
- 1994-09-15 AT AT94928126T patent/ATE160573T1/de not_active IP Right Cessation
- 1994-09-15 EP EP94928126A patent/EP0719276B1/de not_active Expired - Lifetime
- 1994-09-15 JP JP50933695A patent/JP3993228B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-12 GR GR980400045T patent/GR3025872T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69407057D1 (de) | 1998-01-08 |
DK0719276T3 (da) | 1998-08-10 |
AU7728494A (en) | 1995-04-03 |
CA2171740A1 (en) | 1995-03-23 |
US5554603A (en) | 1996-09-10 |
DE69407057T2 (de) | 1998-04-09 |
WO1995007925A1 (en) | 1995-03-23 |
JPH09505802A (ja) | 1997-06-10 |
GR3025872T3 (en) | 1998-04-30 |
JP3993228B2 (ja) | 2007-10-17 |
AU700576B2 (en) | 1999-01-07 |
EP0719276B1 (de) | 1997-11-26 |
ES2110258T3 (es) | 1998-02-01 |
CA2171740C (en) | 2005-07-26 |
EP0719276A1 (de) | 1996-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
NL300017I1 (nl) | Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten. | |
ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
BG99261A (en) | Steroid glycosides for the treatment of hyperchlesterolemia | |
NO965516D0 (no) | Sterolderivater anvendt til regulering av meiose | |
UA43378C2 (uk) | Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих | |
FI925615A0 (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening | |
OA09458A (en) | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof. | |
LU90366I2 (fr) | Nasonex | |
EP0247167A4 (de) | Hydroxy- und aminothiazolyl-benzodiazinonverbindungen, kardiotonische mittel, die diese enthalten und verwendungen. | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
GR1000118B (el) | Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην. | |
DE69300694D1 (de) | Desinfizierende Zusammensetzungen. | |
AU2732597A (en) | Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs | |
SE9604348D0 (sv) | Användning av hydroxyguanidiner | |
MX9601994A (es) | Profarmacos de derivados de paclitaxel. | |
ATE160573T1 (de) | 1,3.5 (10) - estratriene derivate mit oraler wirkung | |
ZA93821B (en) | New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them. | |
MX9200748A (es) | Formulaciones de esteroides. formulaciones de esteroides. | |
ZA973289B (en) | Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them. | |
DE69431662D1 (de) | Stabilisierte tablettenformulierung | |
ZA929879B (en) | Compositions for the treatment of mammalian diseases. | |
FI923751A0 (fi) | Hexahydrobenso/f/kinolinoner. | |
ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge | |
DE68910057D1 (de) | Behandlungszusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |